Senate Vote Splits Usual Partisan Lines on Hemp THC Ban Delay
The Senate’s weekend decision to keep a delay in place for a forthcoming ban on certain hemp‑derived THC products revealed an unexpected cross‑aisle coalition. While the measure to postpone the effective date from November 12 to December 11 survived a 61‑32 vote, the debate highlighted deeper tensions over regulation versus prohibition and the influence of industry lobbying.
Background: From the 2018 Farm Bill to the New THC Limit
Under the 2018 Farm Bill, hemp containing no more than 0.3 % delta‑9 THC on a dry‑weight basis was removed from the federal list of controlled substances. Late last year, Congress passed legislation that redefines legal hemp as any product containing no more than 0.4 milligrams of total THC per container, a threshold set to take effect on November 12, 2026.
Supporters of the change argue that the tighter limit will curb the proliferation of intoxicating hemp products, while opponents warn that a sudden ban could jeopardize thousands of jobs in farming, manufacturing, and retail sectors that have built compliant businesses around the existing 0.3 % standard.
Senate Action: Tabling the Budd Amendment
Sen. Ted Budd (R‑NC) introduced an amendment to strike the delay language and keep the ban on schedule. Sen. Amy Klobuchar (D‑MN) moved to table Budd’s amendment, a procedural maneuver that effectively preserves the delay. The Senate voted 61‑32 to table the amendment, with 34 Democrats, one independent who caucuses with Democrats, and 26 Republicans supporting the move.
Notable senators who voted to keep the delay included Majority Leader John Thune (R‑SD), Minority Leader Chuck Schumer (D‑NY), Sens. Cory Booker (D‑NJ), Ted Cruz (R‑TX), John Fetterman (D‑PA), Rand Paul (R‑KY), Bernie Sanders (I‑VT), Tim Sheehy (D‑MT), and Ron Wyden (D‑OR).
Conversely, 21 Republicans and 11 Democrats voted to keep Budd’s amendment alive, among them Sens. Susan Collins (R‑ME), John Cornyn (R‑TX), Dick Durbin (D‑IL), Kirsten Gillibrand (D‑NY), Chuck Grassley (R‑IA), Jeff Merkley (D‑OR), and Lisa Murkowski (R‑AK).
Statements from the Floor
After the vote, Sen. Klobuchar emphasized that the delay would give Congress additional time to craft a “long‑term fix” rather than resorting to a one‑size‑fits‑all prohibition. She noted that Minnesota’s existing safety rules for hemp products could serve as a model for national legislation.
Sen. Budd, defending his position, argued that the hemp industry had already had nine months to shape policy and that the delay was an attempt to “jam” lawmakers into a must‑pass spending package while entrenching intoxicating products in the marketplace.
Sen. Rand Paul (R‑KY) criticized the push to ban hemp, stating that adults should be free to choose substances like hemp‑derived products for sleep aid, comparing them to prescription medications such as Ambien or Percocet.
Industry Reactions
The U.S. Cannabis Roundtable expressed disappointment, warning that during the August recess House members would hear from constituents about the availability of unregulated synthetic hemp products, including to minors.
Michael Bronstein, president of the American Trade Association for Cannabis and Hemp, cautioned that the Senate’s decision could undermine state efforts to regulate synthetic cannabinoids such as delta‑8 THC, delta‑10 THC, and THCP, which he argues are not true hemp.
In contrast, the U.S. Hemp Roundtable praised the vote, saying it preserves access to lawful hemp products, protects American jobs, and affords Congress the time needed to develop a comprehensive federal regulatory framework.
Thomas Winstanley of Edibles.com highlighted that the extension does not solve the hemp issue but preserves the opportunity to address it correctly through a framework rooted in consumer safety, responsible commerce, and meaningful enforcement.
Looking Ahead
The House of Representatives is set to return from its August recess on August 31 and will consider a funding bill that currently lacks the Senate’s delay provision. Hemp advocates plan to lobby for the Senate’s language to be retained while simultaneously pushing for a regulatory framework to be finalized before the new December 11 deadline.
The vote underscores how issues surrounding hemp and cannabis policy can transcend typical partisan divides, reflecting a complex interplay of public health concerns, economic interests, and differing views on personal liberty.
Source: Here
